Skip to main content

Table 3 Different analyses of total vessel density (TVD) and perfused vessel density (PVD)

From: Effects of endotoxin adsorber hemoperfusion on sublingual microcirculation in patients with septic shock: a randomized controlled trial

Group

Control

PMX-HP

p values

Intent-to-treat analysis

 Number of patients

14

14

 

 T1 TVD (mm/mm2)

20.8 (20.0–24.1)

23.3 (20.9–25.2)

0.069

 T1 PVD (mm/mm2)

19.7 (18.8–23.2)

22.8 (20.9–24.5)

0.085

T2 TVD

21.1 (19.9–22.9)

24.2 (22.1–24.9)

0.007

 T2 PVD

20.0 (18.9–21.6)

22.9 (20.9–24.9)

0.008

As-treated analysis

 Number of patients

13

15

 

 T1TVD

20.5 (19.9–23.4)

23.6 (20.9–25.1)

0.041

 T1 PVD

19.3 (18.7–22.5)

22.9 (20.9–24.4)

0.037

 T2 TVD

20.7 (19.8–22.7)

23.9 (22.1–24.9)

0.003

 T2 PVD

19.8 (18.8–21.0)

23.0 (21.3–24.9)

0.002

Per-protocol analysis

 Number of patients

13

14

 

 T1TVD

20.5 (19.9–23.4)

23.3 (20.9–25.2)

0.048

 T1 PVD

19.3 (18.7–22.5)

22.8 (20.9–24.5)

0.048

 T2 TVD

20.7 (19.8–22.7)

24.2 (22.1–24.9)

0.005

 T2 PVD

19.8 (18.8–21.0)

22.9 (20.9–24.9)

0.004

  1. Data are presented as median (interquartile range)
  2. PMX-HP polymyxin B hemoperfusion